Zyprexa olanzapine regulatory update

FDA approved sNDAs from Eli Lilly for oral Zyprexa olanzapine to treat schizophrenia and manic or mixed episodes associated with bipolar I disorder in patients 13-17 years of age. In June, an FDA advi...